Aridis Pharmaceuticals Inc (ARDS)

Aridis Pharmaceuticals Inc (ARDS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4,457; returns 1 day +100.0%.

Aridis Pharmaceuticals Inc. is a late-stage biopharmaceutical company that focuses on discovering and developing targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening infections.

Groups ARDS belongs to

• Biotechnology
• Biopharmaceutical
• Monoclonal Antibodies
• Immunotherapy
• Infectious Diseases
• Clinical Stage Biopharma
• Clinical Stage
• Healthcare
• Cystic Fibrosis Therapies
• Life Sciences

ARDS financial model: income statement, cash flow and balance sheet